Guardian Pharmacy Services Overview
Latest ROE for Guardian Pharmacy Services: 24.02% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow24.02%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Guardian Pharmacy Services (GRDN) currently reports a ROE of 24.02%. That is above the sector sector average of -4.47%. Use the charts on this page to explore Guardian Pharmacy Services's ROE history and peer comparisons.
Guardian Pharmacy Services's ROE of 24.02% is higher than the its sector sector average of -4.47%. That is roughly 637.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Guardian Pharmacy Services's current 24.02% should be judged against industry norms (sector average: -4.47%) and against GRDN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 24.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for Guardian Pharmacy Services, and consider following GRDN for alerts when major investors trade the stock.
